Skip to content

FERN: Intervention or expectant management for early onset selective fetal growth restriction in monochorionic twin pregnancy

FERN: Intervention or expectant management for early onset selective fetal growth restriction in monochorionic twin pregnancy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN16879394
Enrollment
100
Registered
2023-08-15
Start date
2022-06-15
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Monochorionic (MC) twin pregnancies with early-onset (prior to 24 weeks) selective fetal growth restriction (sFGR) Pregnancy and Childbirth

Interventions

A mixed-methods study has been designed to explore the current management of sFGR in MC twin pregnancy. This information will be used to inform a subsequent RCT comparing management options
intervention versus expectant management. The study design involves 3 work packages, 1) a prospective UK multicentre study, 2) a qualitative study of women's and clinical staff's views and 3) an int

Sponsors

University of Liverpool
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. MC diamniotic twin pregnancy 2. Diagnosis of sFGR (EFW of one twin 25%) 3. Gestational age at diagnosis between 16+0 - 23+6 weeks based on ultrasound 4. Informed consent given by the participant and the consent form completed and signed

Exclusion criteria

Exclusion criteria: 1. Singleton pregnancies 2. Maternal age under 18 years 3. TTTS 4. Twin anaemia polycythaemia sequence before enrolment 5. Other rare complicated MC twin pregnancies, such as twin reversed arterial perfusion syndrome 6. Known karyotype abnormality at enrolment 7. Known major fetal structural abnormality at enrolment, defined as a lethal, incurable or curable severe abnormality with a high risk of residual handicap 8. Indication for immediate delivery 9. Pre-term pre-labour rupture of membranes before enrolment 10. Women who lack the capacity to give informed consent 11. Any medical condition that compromises the woman’s ability to participate

Design outcomes

Primary

MeasureTime frame
The feasibility of conducting an RCT of active intervention versus expectant management in MC twin pregnancies with early-onset (prior to 24 weeks) sFGR will be measured using the following methods within the approved study timeline: Work Package 1 - A collection of prospective data on the management and clinical outcomes of MC pregnancies complicated by sFGR (data collection from prospective eligible pregnancies from informed consent date to date of maternal discharge) Work Package 2 - Perform a qualitative study involving interviews and focus groups with parents and clinicians to explore trial design, acceptability, feasibility and decision-making related to intervention or expectant management (qualitative interviews and focus groups) Work Package 3 - Using information provided in work packages 1 and 2 to develop a consensus on a future definitive study (questionnaire and focus groups)

Secondary

MeasureTime frame
There are no secondary outcome measures

Countries

England, Northern Ireland, Scotland, United Kingdom

Contacts

Public ContactTracey Ricketts
ricketts@liverpool.ac.uk+44 (0)1517959562

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 5, 2026